• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by N2OFF Inc.

    5/15/25 4:01:02 PM ET
    $NITO
    Agricultural Chemicals
    Industrials
    Get the next $NITO alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    N2OFF, Inc.

    (Name of Issuer)


    Common Stock, $0.0001 par value per share

    (Title of Class of Securities)


    80512Q302

    (CUSIP Number)


    05/15/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    80512Q302


    1Names of Reporting Persons

    Kfir Silberman
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    ISRAEL
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    14,286.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    14,286.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    2,064,286.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    7.81 %
    12Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:  (1) Kfir Silberman is the officer, sole director, chairman of the board of directors and control shareholder of L.I.A Pure Capital Ltd ("Pure Capital"). (2) Mr. Silberman is the beneficial owner of 2,064,286 shares of Common Stock consisting of (a) 14,286 shares of Common Stock are held directly by Mr. Silberman, (b) 1,050,000 shares of Common Stock held by Pure Capital, and (c) 1,000,000 shares of Common Stock issuable upon exercise of the Warrants held by Pure Capital, which are exercisable within 60 days of the date hereof, which exercise is subject to the 9.99% Blocker. (3) Based on 26,433,237 shares of Common Stock issued and outstanding, according to information provided by the Issuer.


    SCHEDULE 13G

    CUSIP No.
    80512Q302


    1Names of Reporting Persons

    L.I.A Pure Capital Ltd.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    ISRAEL
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    1,050,000.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,050,000.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    2,064,286.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    7.81 %
    12Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:  (1) Kfir Silberman is the officer, sole director, chairman of the board of directors and control shareholder of Pure Capital. (2) Pure Capital is the beneficial owner of 2,050,000 shares of Common Stock consisting of (a) 1,050,000 shares of Common Stock held by Pure Capital, and (b) 1,000,000 shares of Common Stock issuable upon exercise of the Warrants held by Pure Capital, which are exercisable within 60 days of the date hereof, which exercise is subject to the 9.99% Blocker. (3) Based on 26,433,237 shares of Common Stock issued and outstanding, according to information provided by the Issuer.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    N2OFF, Inc.
    (b)Address of issuer's principal executive offices:

    HaPardes 134 (Meshek Sander), Neve Yarak, Israel, 4994500
    Item 2. 
    (a)Name of person filing:

    L.I.A Pure Capital Ltd.
    (b)Address or principal business office or, if none, residence:

    20 Raoul Wallenberg Suite 1001 Tel Aviv Israel 6971916
    (c)Citizenship:

    Israel
    (d)Title of class of securities:

    Common Stock, $0.0001 par value per share
    (e)CUSIP No.:

    80512Q302
    Item 4.Ownership
    (a)Amount beneficially owned:

    See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.
    (b)Percent of class:

    See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.

     (ii) Shared power to vote or to direct the vote:

    See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.

     (iii) Sole power to dispose or to direct the disposition of:

    See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.

     (iv) Shared power to dispose or to direct the disposition of:

    See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein.

    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Kfir Silberman
     
    Signature:/s/ Kfir Silberman
    Name/Title:Kfir Silberman
    Date:05/15/2025
     
    L.I.A Pure Capital Ltd.
     
    Signature:/s/ L.I.A. PURE CAPITAL LTD.
    Name/Title:Kfir Silberman, CEO
    Date:05/15/2025
    Get the next $NITO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NITO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NITO
    SEC Filings

    View All

    N2OFF Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - N2OFF, Inc. (0001789192) (Filer)

    1/13/26 4:05:53 PM ET
    $NITO
    Agricultural Chemicals
    Industrials

    N2OFF Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

    8-K - N2OFF, Inc. (0001789192) (Filer)

    1/12/26 9:15:22 AM ET
    $NITO
    Agricultural Chemicals
    Industrials

    N2OFF Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Submission of Matters to a Vote of Security Holders

    8-K - N2OFF, Inc. (0001789192) (Filer)

    12/16/25 4:05:32 PM ET
    $NITO
    Agricultural Chemicals
    Industrials

    $NITO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Silberman Alon claimed ownership of 454,127 shares (SEC Form 3)

    3 - N2OFF, Inc. (0001789192) (Issuer)

    10/28/25 4:05:14 PM ET
    $NITO
    Agricultural Chemicals
    Industrials

    New insider Scisparc Ltd. claimed ownership of 490,751 shares (SEC Form 3)

    3 - N2OFF, Inc. (0001789192) (Issuer)

    10/24/25 4:05:27 PM ET
    $NITO
    Agricultural Chemicals
    Industrials

    Chief Financial Officer Barda Lital was granted 300,000 units of Restricted Shares of Common Stock (SEC Form 4)

    4 - N2OFF, Inc. (0001789192) (Issuer)

    5/12/25 4:10:18 PM ET
    $NITO
    Agricultural Chemicals
    Industrials

    $NITO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    In Spaceflight Conditions: N2OFF's MitoCareX Bio Highlights Co-Founder's Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions

    Neve Yarak, Israel, Feb. 02, 2026 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ:NITO) ("N2OFF" and the "Company"), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, today highlighted a newly published peer-reviewed study co-authored by Prof. Ciro Leonardo Pierri, co-founder of MitoCareX Bio Ltd. ("MitoCareX Bio"), a specialty biotechnology company developing small‑molecule drugs that target human mitochondrial carriers, its wholly- owned subsidiary. The article, appearing in the Journal of Translational Medicine, investigates SLC25A mitochondrial carriers as potential biomarkers and therapeutic targets for dysfunctions induce

    2/2/26 8:05:00 AM ET
    $NITO
    Agricultural Chemicals
    Industrials

    N2OFF: MitoCareX Bio Announces Positive In Vitro Results from Its Mitochondrial Carrier Small Molecule Platform

    MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory Metabolic Diseases – A Market Projected to Exceed $120 billion by 2030 Neve Yarak, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ:NITO) ("N2OFF" and the "Company"), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, today announced that MitoCareX Bio Ltd. ("MitoCareX Bio"), a specialty biotechnology company developing small‑molecule drugs that target human mitochondrial carriers, its wholly- owned subsidiary, has shown preliminary in vitro data demonstrating inhibition of pro‑inflamm

    1/22/26 7:32:00 AM ET
    $NITO
    Agricultural Chemicals
    Industrials

    N2OFF: MitoCareX Bio Spotlights Co-Founder's Pioneering Research on Mitochondrial Carriers in Spaceflight Stress Conditions

    Neve Yarak, Israel, Jan. 15, 2026 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ:NITO) ("N2OFF" and the "Company"), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, today highlighted a newly published peer-reviewed study co-authored by Prof. Ciro Leonardo Pierri, co-founder of MitoCareX Bio Ltd. ("MitoCareX Bio"), N2OFF's wholly-owned subsidiary. The article, appearing in the Journal of Translational Medicine, investigates SLC25A mitochondrial carriers as potential biomarkers and therapeutic targets for dysfunctions induced by spaceflight conditions, including microgravity and cosmic radiation. The study, titled "SLC25A mito

    1/15/26 8:32:00 AM ET
    $NITO
    Agricultural Chemicals
    Industrials

    $NITO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rosenbloom Ronen bought 50,000 units of Restricted Shares of Common Stock, increasing direct ownership by 345% to 64,500 units (SEC Form 4)

    4 - N2OFF, Inc. (0001789192) (Issuer)

    12/26/24 7:42:11 AM ET
    $NITO
    Agricultural Chemicals
    Industrials

    $NITO
    Financials

    Live finance-specific insights

    View All

    N2OFF Announces Strategic Initiatives Intended to Maximize Shareholder Value

    Neve Yarak, Israel, Oct. 02, 2024 (GLOBE NEWSWIRE) -- N2OFF, Inc.\ (NASDAQ:NITO) (FSE:80W) ("N2OFF" or the "Company"), a clean tech company engaged in sustainable solutions for the energy and agri-tech industries, announced today key strategic initiatives approved by its board of directors (the "Board") that are intended to increase shareholder value. Key Highlights of the Board's Initiatives Spin-off of cleantech activities: N2OFF is considering pursuing a potential spin-off of its cleantech operations - NTWO OFF Ltd. and Save Foods Ltd. – into a separate publicly traded company with the intention of listing that spin-off company on a national exchange. In connection with the potential

    10/2/24 8:30:00 AM ET
    $NITO
    Agricultural Chemicals
    Industrials